GLP1R and Hyperinsulinemia: GLP-1 RAs enhance insulin sensitivity by increasing signaling in skeletal muscle, liver, and adipose tissue, reduce hyperinsulinemia through improved pancreatic β-cell function, and facilitate weight loss by addressing adipose tissue dysfunction [125,126,127].